Edition:
United Kingdom

Menlo Therapeutics Inc (MNLO.OQ)

MNLO.OQ on NASDAQ Stock Exchange Global Select Market

9.49USD
22 May 2018
Change (% chg)

$0.49 (+5.44%)
Prev Close
$9.00
Open
$9.15
Day's High
$9.49
Day's Low
$9.15
Volume
5,346
Avg. Vol
--
52-wk High
$38.68
52-wk Low
$6.99

Select another date:

Wed, May 9 2018

BRIEF-Menlo Therapeutics Reports Qtrly Loss Per Share $0.72

* MENLO THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-Menlo Therapeutics Says Japanese Phase 2 Trial Of Serlopitant Halted

* MENLO THERAPEUTICS - CO'S PARTNERS FOR COMMERCIALIZATION OF SERLOPITANT IN JAPAN, INFORMED DECISION TO HALT JAPANESE PHASE 2 CLINICAL TRIAL OF SERLOPITANT

BRIEF-Menlo Therapeutics Reports Q4 Loss Of $1.80 Per Share

* MENLO THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

BRIEF-Novo Holdings Reports 5.05 Pct Passive Stake In Menlo Therapeutics

* NOVO HOLDINGS A/S REPORTS 5.05 PERCENT PASSIVE STAKE IN MENLO THERAPEUTICS INC, AS OF JANUARY 29, 2018 - SEC FILING‍​ Source text: (http://bit.ly/2nSBUJu) Further company coverage:

BRIEF-Menlo Therapeutics Now Sees IPO Of 6.5 Mln Shares Of Common Stock Priced Between $16 And $17 Per Share

* MENLO THERAPEUTICS INC NOW SEES IPO OF 6.5 MILLION SHARES OF COMMON STOCK PRICED BETWEEN $16.00 AND $17.00 PER SHARE - SEC FILING

Select another date: